Check Before You Invest : Astrazeneca Pharma India Ltd

Snapshot

Q.1 Which industry/sub-sector does Astrazeneca Pharma India Ltd belong to?

Astrazeneca Pharma India Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Astrazeneca Pharma India Ltd a good quality company?

Astrazeneca Pharma India Ltd is a good quality company, based on a consistently good 10-year financial track record.

Q.3 Is Astrazeneca Pharma India Ltd undervalued or overvalued?

Astrazeneca Pharma India Ltd appears Overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Astrazeneca Pharma India Ltd a good buy now?

Astrazeneca Pharma India Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd revenue growth is 32.5% for FY-2025, which is above its 5-year CAGR of 15.59%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Return on capital employed is 21.29% for FY-2025, which is below its 5-year historical median of 24.49%. The current ROCE is above its estimated weighted average cost of capital (WACC) of 13.5%, indicating value creation.

Q.3 Return on Asset of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Return on Asset is 7.43%, which is below its 5-year historical median of 9.37%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Return on equity is 15.73% for FY-2025, which is below its 5-year historical median of 18.13%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Cash conversion cycle is 50 days, above its 5-year historical median of 6 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	1.11	0.99
ROE	15.73	18.13
ROCE	21.29	24.49
Cash Conversion Cycle	50 days	6 days

Q.6 Gross Profit margin of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Gross profit margin which is the profit after deduction of direct costs, is 17% for FY-2025, which is in line with its 5-year median of 17%, indicating stable margins.

Q.7 Operating Profit Margin of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 14.82% for FY-2025, which is in line with its 5-year median of 14.82% indicating stable margins.

Q.8 Net Profit Margin of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Net Profit Margin is 6.74% for FY-2025, is below with its 5-year median of 9.9%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	17	17
Operating Profit Margin	14.82	14.82
Net Profit Margin	6.74	9.9

Q.9 Debt to Equity ratio of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Debt-to-Equity ratio is 0.00, which is lower with the industry average of 0.27, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Astrazeneca Pharma India Ltd?

Astrazeneca Pharma India Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Astrazeneca Pharma India Ltd?

Promoters hold 75.00% of the Astrazeneca Pharma India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Astrazeneca Pharma India Ltd vs industry peers?

Astrazeneca Pharma India Ltd revenue CAGR is 15.59%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	32.5	8.3
Gross Profit Growth	34.4	14.7
Operating Profit Growth	38	11.4
Net Profit Growth	-28.4	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	1.11	0.81
ROE	15.73	9.49
ROCE	21.29	11.91
Cash Conversion Cycle (days)	49.9	85

Valuation & price assessment

Q.1 Stock return of Astrazeneca Pharma India Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 21.5% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	21.5%	16.1%	36%	-3.6%

Q.3 Valuation ratios of Astrazeneca Pharma India Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	100.14	106.67	31.09
Price to Book	24.19	18.92	2.85
Price to Sales	9.24	10.41	2.79
EV to EBITDA	60.45	62.15	15.87

Check more companies

5. Wockhardt

8. Pfizer

10. Neuland Laboratories

Check trending companies

1. Devyani International Ltd.

2. Bharat Forge Ltd.

3. Atul Ltd.

4. Tata Chemicals Ltd.

5. Bajaj Housing Finance Ltd.